TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02490098

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Funding terminated”

The sponsor’s own words in the registry.

Life of this trial

20152016201720182019Registered2015-07-01Withdrawn (as of)2017-10-27Planned start2018-01 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Institut de Recherches Cliniques de Montreal
Sponsor type
University, hospital or other
Conditions
Type 1 Diabetes
Interventions
6-day intervention with sensor-augmented pump therapy; 6-day intervention with single-hormone closed-loop strategy; 6-day intervention with dual-hormone closed-loop strategy; Insulin; Glucagon; Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Participants
0
Sites
1
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.